Free Trial

Lakeshore Biopharma (LSB) Short Interest Ratio & Short Volume

Lakeshore Biopharma logo
$1.32 -0.18 (-12.07%)
Closing price 04/17/2025 03:58 PM Eastern
Extended Trading
$1.25 -0.06 (-4.85%)
As of 04/17/2025 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lakeshore Biopharma Short Interest Data

Lakeshore Biopharma (LSB) has a short interest of 13,300 shares, representing 0.40% of the float (the number of shares available for trading by the public). This marks a 84.72% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 20,980 shares to cover all short positions.

Current Short Interest
13,300 shares
Previous Short Interest
7,200 shares
Change Vs. Previous Month
+84.72%
Dollar Volume Sold Short
$30,669.80
Short Interest Ratio
1.0 Days to Cover
Last Record Date
March 31, 2025
Outstanding Shares
9,306,000 shares
Float Size
3,300,000 shares
Short Percent of Float
0.40%
Today's Trading Volume
29,789 shares
Average Trading Volume
20,980 shares
Today's Volume Vs. Average
142%
Short Selling Lakeshore Biopharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Lakeshore Biopharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LSB Short Interest Over Time

LSB Days to Cover Over Time

LSB Percentage of Float Shorted Over Time

Lakeshore Biopharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202513,300 shares $30,669.80 +84.7%0.4%1 $2.31
3/15/20257,200 shares $14,688.00 -1.4%0.2%0.4 $2.04
2/28/20257,300 shares $16,169.50 -33.6%0.2%0.5 $2.22
2/15/202511,000 shares $26,400.00 +11.1%0.3%0.6 $2.40
1/31/20259,900 shares $25,641.00 -27.2%0.3%0.3 $2.59
1/15/202513,600 shares $30,872.00 -42.6%0.4%0.3 $2.27
12/31/202423,700 shares $82,002.00 -35.3%0.7%0.5 $3.46
12/15/202436,600 shares $91,317.00 +22.0%1.1%0.8 $2.50
11/30/202430,000 shares $82,500.00 -36.8%0.9%0.7 $2.75
11/15/202447,500 shares $119,700.00 +239.3%1.4%1.2 $2.52
10/31/202414,000 shares $32,620.00 +75.0%0.4%0.4 $2.33
10/15/20248,000 shares $30,240.00 -4.8%0.3%0.5 $3.78
9/30/20248,400 shares $5,728.80 -70.4%0.3%0.7 $0.68
9/15/202428,400 shares $17,011.60 +38.5%0.1%0.8 $0.60
8/31/202420,500 shares $9,061.00 -10.9%0.1%0.8 $0.44
8/15/202423,000 shares $10,373.00 -12.6%0.1%0.6 $0.45
7/31/202426,300 shares $11,819.22 +20.1%0.1%0.5 $0.45
7/15/202421,900 shares $9,732.36 No Change0.1%0.4 $0.44

LSB Short Interest - Frequently Asked Questions

What is Lakeshore Biopharma's current short interest?

Short interest is the volume of Lakeshore Biopharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 13,300 shares of LSB short. 0.40% of Lakeshore Biopharma's shares are currently sold short. Learn More on Lakeshore Biopharma's current short interest.

What is a good short interest ratio for Lakeshore Biopharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LSB shares currently have a short interest ratio of 1.0. Learn More on Lakeshore Biopharma's short interest ratio.

What is a good short interest percentage for Lakeshore Biopharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.40% of Lakeshore Biopharma's floating shares are currently sold short.

Is Lakeshore Biopharma's short interest increasing or decreasing?

Lakeshore Biopharma saw a increase in short interest in March. As of March 31st, there was short interest totaling 13,300 shares, an increase of 84.7% from the previous total of 7,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Lakeshore Biopharma's float size?

Lakeshore Biopharma currently has issued a total of 9,306,000 shares. Some of Lakeshore Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lakeshore Biopharma currently has a public float of 3,300,000 shares.

How does Lakeshore Biopharma's short interest compare to its competitors?

0.40% of Lakeshore Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lakeshore Biopharma: Renovaro Inc. (6.87%), Alto Neuroscience, Inc. (15.96%), Cabaletta Bio, Inc. (13.92%), Acrivon Therapeutics, Inc. (4.08%), Metagenomi, Inc. (12.26%), Pyxis Oncology, Inc. (16.77%), Precision BioSciences, Inc. (21.82%), Ikena Oncology, Inc. (0.82%), Kronos Bio, Inc. (1.56%), Avalo Therapeutics, Inc. (1.36%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

What does it mean to sell short Lakeshore Biopharma stock?

Short selling LSB is an investing strategy that aims to generate trading profit from Lakeshore Biopharma as its price is falling. LSB shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Lakeshore Biopharma?

A short squeeze for Lakeshore Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LSB, which in turn drives the price of the stock up even further.

How often is Lakeshore Biopharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LSB, twice per month. The most recent reporting period available is March, 31 2025.




This page (NASDAQ:LSB) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners